{"id":24837,"date":"2025-09-18T16:56:11","date_gmt":"2025-09-18T14:56:11","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/"},"modified":"2025-09-18T17:02:58","modified_gmt":"2025-09-18T15:02:58","slug":"deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/","title":{"rendered":"Deimos Group and Variati join forces to shape the future of Life Sciences"},"content":{"rendered":"

BY THE COMPANY<\/span><\/p>\n

The Life Sciences landscape in Italy and across Europe is undergoing profound transformation, driven by growing demand for innovative nutraceutical and cosmetic solutions. In this context, Deimos Group strengthens its role as a leading player with the acquisition of Variati S.p.A.<\/strong>, a historic company founded in 1926 and internationally recognized as a trusted partner in the distribution of ingredients and raw materials.<\/p>\n

This operation marks an important milestone in the Group\u2019s growth strategy, consolidating its position in the nutraceutical and cosmetic segments, while complementing its already broad and structured offering across food, pharmaceutical, chemical, agricultural and pet food markets.<\/p>\n

\n

Variati S.p.A., nearly a century of excellence<\/h3>\n

Founded in Milan almost a hundred years ago, Variati S.p.A. has built its reputation on three key pillars: quality, innovation, and long-standing partnerships. Over the years, the company has become a benchmark supplier of premium active ingredients and raw materials, particularly through its \u201cVariati Specialties\u201d line of natural ingredients \u2014 a brand that will continue to embody reliability, safety, and added value.<\/p>\n

With its strong technical expertise and ability to anticipate market needs, Variati has become a point of reference for clients and partners both in Italy and internationally.<\/p>\n<\/blockquote>\n

Synergies with Deimos Group<\/h2>\n

For Deimos Group, integrating Variati is not just a commercial expansion, but a strategic investment aimed at creating new growth opportunities for suppliers and clients alike. The combination of complementary expertise will enable the delivery of even more innovative solutions<\/strong>, a broader product portfolio, and highly qualified technical support to guide the development of new nutraceutical and cosmetic products.<\/p>\n

Hans Udo Wenzel, Chairman of Deimos Group<\/strong>, stated: \u201cVariati S.p.A. is a company with an extraordinary history and a solid reputation, built on valuable relationships, technical expertise, and entrepreneurial integrity. We are proud to welcome such an experienced team into our Group. Together, we will strengthen our presence in the nutraceutical and cosmetic segments with an increasingly distinctive and innovative product offering.\u201d<\/em><\/p>\n

Continuity and future with the Variati Specialties brand<\/h2>\n

For Variati\u2019s long-standing partners, the acquisition ensures continuity while opening new horizons. Robin Variati, Chairman of the company, emphasized<\/strong>: \u201cBecoming part of Deimos Group is a natural evolution and a strategic opportunity to enhance our experience, history, and partnerships built over time. The Variati Specialties brand will continue to embody the qualities that have distinguished us for decades. We are excited to begin this new journey, which will allow us to offer our customers and partners a broader, more innovative, and future-oriented product portfolio.\u201d<\/em><\/p>\n

The shared goal is clear: to combine the solidity of a near-century-long tradition with Deimos Group\u2019s innovation-driven<\/strong>, international vision, in order to respond to the evolving demands of global markets.<\/p>\n

Opportunities for suppliers and the market<\/h2>\n

The integration of Variati into Deimos Group also brings significant advantages for suppliers, who will benefit from a more structured partner with broader market presence and stronger capabilities<\/strong>. The move further consolidates the Group\u2019s position as a preferred partner for companies aiming to develop technically advanced, high-quality products.<\/p>\n

In an increasingly selective and regulated market, the value of a reliable and solid partner becomes decisive in ensuring continuity, safety, and innovation. With this acquisition, Deimos Group positions itself as a leading force in a new model of distribution and technical consulting, one that combines expertise with strategic vision.<\/p>\n

\n

Deimos Group, a growing force<\/h2>\n

Headquartered in Cologno Monzese, Deimos Group is today a leading player in the distribution of raw materials in Italy. Its activities extend to the food, cosmetics, nutraceutical, pharmaceutical, chemical, agricultural, and pet food industries, through a portfolio that combines innovative solutions with specialized technical consulting services.<\/p>\n

The Group is distinguished by its ability to support clients in developing high-quality, competitive products, blending technical expertise with reliability and an attentive eye on the evolving needs of the global market.<\/p>\n<\/blockquote>\n

A new phase of shared growth<\/h2>\n

The inclusion of Variati into Deimos Group marks the beginning of a new phase, where the combination of expertise and experience serves as a driving force to face future challenges. The synergy between the two companies promises to strengthen innovation capacity, broaden the offering, and consolidate positioning in rapidly evolving markets.<\/p>\n

More than a simple acquisition, this is a partnership designed to create value for clients, suppliers, and stakeholders<\/strong> \u2014 built on quality, sustainability, and a relentless pursuit of distinctive solutions.<\/p>\n","protected":false},"excerpt":{"rendered":"

With the entry of Variati S.p.A. into Deimos Group, a center of excellence is created in the distribution of ingredients and raw materials for the nutraceutical and cosmetic sectors. A synergy that combines nearly a century of history with a strategic vision focused on innovation and international leadership.<\/p>\n","protected":false},"author":32,"featured_media":24835,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1004],"tags":[],"class_list":{"0":"post-24837","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-business-en-2"},"yoast_head":"\nDeimos Group e Variati, acquisizione<\/title>\n<meta name=\"description\" content=\"Variati acquisita da Deimos Group: eccellenza nella distribuzione di ingredienti e materie prime per i settori nutraceutico e cosmetico\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Deimos Group e Variati, acquisizione\" \/>\n<meta property=\"og:description\" content=\"Variati acquisita da Deimos Group: eccellenza nella distribuzione di ingredienti e materie prime per i settori nutraceutico e cosmetico\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-18T14:56:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-18T15:02:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png\" \/>\n\t<meta property=\"og:image:width\" content=\"696\" \/>\n\t<meta property=\"og:image:height\" content=\"696\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"headline\":\"Deimos Group and Variati join forces to shape the future of Life Sciences\",\"datePublished\":\"2025-09-18T14:56:11+00:00\",\"dateModified\":\"2025-09-18T15:02:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/\"},\"wordCount\":741,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png\",\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/\",\"name\":\"Deimos Group e Variati, acquisizione\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png\",\"datePublished\":\"2025-09-18T14:56:11+00:00\",\"dateModified\":\"2025-09-18T15:02:58+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"description\":\"Variati acquisita da Deimos Group: eccellenza nella distribuzione di ingredienti e materie prime per i settori nutraceutico e cosmetico\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Deimos Group and Variati join forces to shape the future of Life Sciences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Deimos Group e Variati, acquisizione","description":"Variati acquisita da Deimos Group: eccellenza nella distribuzione di ingredienti e materie prime per i settori nutraceutico e cosmetico","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/","og_locale":"en_US","og_type":"article","og_title":"Deimos Group e Variati, acquisizione","og_description":"Variati acquisita da Deimos Group: eccellenza nella distribuzione di ingredienti e materie prime per i settori nutraceutico e cosmetico","og_url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2025-09-18T14:56:11+00:00","article_modified_time":"2025-09-18T15:02:58+00:00","og_image":[{"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png","width":696,"height":696,"type":"image\/png"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"headline":"Deimos Group and Variati join forces to shape the future of Life Sciences","datePublished":"2025-09-18T14:56:11+00:00","dateModified":"2025-09-18T15:02:58+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/"},"wordCount":741,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png","articleSection":["Business"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/","url":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/","name":"Deimos Group e Variati, acquisizione","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png","datePublished":"2025-09-18T14:56:11+00:00","dateModified":"2025-09-18T15:02:58+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"description":"Variati acquisita da Deimos Group: eccellenza nella distribuzione di ingredienti e materie prime per i settori nutraceutico e cosmetico","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2025\/09\/2d0ab635-af09-4886-9ba0-60abc4b91ea7.png","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/deimos-group-e-variati-insieme-per-guidare-il-futuro-del-life-science\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"Deimos Group and Variati join forces to shape the future of Life Sciences"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24837","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=24837"}],"version-history":[{"count":3,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24837\/revisions"}],"predecessor-version":[{"id":24840,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/24837\/revisions\/24840"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/24835"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=24837"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=24837"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=24837"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}